Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-009943)

Filing Details

Accession Number:: 0001209191-14-009943
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-12 19:56:29
Reporting Period:: 2014-02-10

Filing Date:: 2014-02-12
Accepted Time:: 2014-02-12 19:56:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1571498	Epizyme Inc.	EPZM	Pharmaceutical Preparations (2834)	261349956

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1577021	A Robert Copeland	C/O Epizyme, Inc. 400 Technology Square Cambridge MA 02139	Evp And Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-02-10	19,179	$29.25	24,911	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	25,931	Indirect	By Wife

Footnotes

The sale transaction reported on this Form 4 was effected as a part of an underwritten public offering of common stock by Epizyme, Inc. with the Reporting Person as a selling stockholder in the offering.